US 9951118
Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 9951118 (Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors) held by The Regents of the University of California expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K35/28, A61K40/11